iAnthus Capital (ITHUF) Stock Price, News & Analysis

Company Overview

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.0054 to $0.0065
• 50-Day Range: $0.0063 to $0.0133
• 52-Week Range: $0.01 to $0.04
• Volume: 47,609 shs
• Average Volume: 160,888 shs
• Market Capitalization: N/A
• P/E Ratio: 0.04
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iAnthus Capital Stock Analysis - MarketRank™

iAnthus Capital scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iAnthus Capital.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iAnthus Capital is 0.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.59.

Price to Earnings Ratio vs. Sector

The P/E ratio of iAnthus Capital is 0.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 131.37.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

iAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iAnthus Capital has recently increased by 276.19%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iAnthus Capital does not currently pay a dividend.

Dividend Growth

iAnthus Capital does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

iAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iAnthus Capital has recently increased by 276.19%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: N/A

News Sentiment

iAnthus Capital has a news sentiment score of -0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iAnthus Capital insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.34% of the stock of iAnthus Capital is held by institutions.

ITHUF Stock Analysis - Frequently Asked Questions

How have ITHUF shares performed this year?

iAnthus Capital's stock was trading at $0.0268 on January 1st, 2024. Since then, ITHUF stock has decreased by 76.5% and is now trading at $0.0063.
View the best growth stocks for 2024 here.

How do I buy shares of iAnthus Capital?

Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:ITHUF
• CUSIP: N/A
• CIK: 1643154
• Web: www.ianthuscapital.com
• Phone: 646-518-9411
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 0.04
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A